Aligning Science Across Parkinson's Logo Text

Consortia

Scientific progress can be accelerated when the community works together in a collaborative, rather than competitive manner. Aligning Science Across Parkinson’s (ASAP) is proud to coordinate with other organizations that promote the sharing of knowledge and resources for the scientific community. Membership in these organizations allows us to work together with the research community to accelerate scientific advances by fostering a collaborative and open approach to research.
Learn more about our memberships below.

Memberships

Research Software Alliance

Research Software Alliance

ASAP is proud to join the Research Software Alliance (ReSA) as an organizational member. ReSA is dedicated to advancing the research software ecosystem by collaborating with decision-makers and key influencers.

Explore

Plan S

Plan S

ASAP is a proud member of Plan S, an initiative for Open Access publishing. The plan is supported by cOAlition S, an international consortium of research funding and performing organizations. Plan S requires that, from 2021, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms.

Explore

Open Research Funders Group

Open Research Funders Group

ASAP is proud to join alongside philanthropic organizations as a member of The Open Research Funders Group (ORFG). ORFG is a partnership of funding organizations committed to the open sharing of research outputs and other forms of scholarship. The ORFG has two primary programmatic pillars: (1) engaging philanthropies in a community of practice to develop, implement, oversee, and advance strategies that accelerate access to funded research, including papers and data; and (2) serving as the funders’ voice in cross-sector discussions about open research policies, incentives, infrastructure, and good practices.

Explore

AMP® PDRD

AMP® PDRD

The Accelerating Medicine Partnership in Parkinson’s Disease and Related Disorders (AMP® PDRD) is a public-private partnership between the National Institutes of Health (NIH), multiple biopharmaceutical and life science companies, and nonprofit organizations. Managed through the Foundation for the NIH (FNIH), AMP® PDRD aims to harmonize Parkinson’s and related disease datasets across the community with the goal of identifying and validating diagnostic, prognostic, and/or progression biomarkers for Parkinson’s disease, with an emphasis on broadening data sharing in the biomedical community to advance Parkinson’s research. ASAP is proud to be a partner in the AMP® PDRD effort to broaden data sharing in the biomedical community to advance Parkinson’s research. Both GP2 and PPMI cohorts share their data on this platform.

Explore

News & Updates

Our initiative is accelerating the pace of discovery for Parkinson’s disease through collaboration, research-enabling resources, and data sharing.

ASAP Research Round-Up | Q1 2026
ASAP Research Round-Up | Q1 2026

April 15, 2026

In this edition of the ASAP Research Round-Up, ASAP presents Q1 2026 highlights from across its portfolio, showcasing efforts to advance Parkinson’s discovery, facilitate the rapid global exchange of ideas, broaden open-science accessibility, and support the next generation of Parkinson’s researchers.

Learn More
Listen: Building a Global Genetic Map of Parkinson’s with Andy Singleton and Ignacio Mata
Listen: Building a Global Genetic Map of Parkinson’s with Andy Singleton and Ignacio Mata

February 10, 2026

On genomics podcast Mendelspod, Andy Singleton, co-lead of the Global Parkinson's Genetics Program (GP2), and Nacho Mata, Cleveland Clinic geneticist and LARGE-PD founder, discuss how GP2 is accelerating discovery and expanding global representation in Parkinson’s research.

Learn More
CMUL Commissions Parkinson’s Disease Research Lab
CMUL Commissions Parkinson’s Disease Research Lab

January 27, 2026

Reports that the College of Medicine, University of Lagos (CMUL) commissioned the GP2–CMUL Molecular Laboratory to strengthen Parkinson’s disease research, genomics capacity, and training opportunities across Africa in collaboration with Aligning Science Across Parkinson’s (ASAP) and the Global Parkinson’s Genetics Program (GP2).

Learn More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.